Launching Soon

The Eating Decision
Operating System
for GLP-1 Medications.

Eliminate nausea, personalize your titration journey, and maintain muscle mass. Powered by Patent-Pending N-of-1 Bayesian inference.

Start Your Journey (App)
✓ Patent Pending AI Architecture
✓ 8-Layer Clinical Safety Veto System
✓ Designed for Semaglutide, Tirzepatide, Liraglutide, & Dulaglutide.
Biological Veto PASSED No Trigger Thresholds Crossed
PK Dose 2.4 mg Peak
Volumetric Risk Low (0.05v)

Stop Guessing What to Eat
on GLP-1s.

GLP-1 medications are life-changing, but navigating the GI side effects (nausea, vomiting, delayed gastric emptying) is a daily struggle. A single "wrong" ingredient can ruin your week. Standard diet apps track calories, but they don't understand the complex pharmacokinetics of your medication.

The "Wow" Factor

Patent-Pending N-of-1 Causal Inference

Beezam isn't a calorie counter. It's a localized, on-device intelligence engine that learns your unique biology.

  • 1
    Bayesian Posterior Updating

    Beezam dynamically updates the risk profile of every ingredient you eat based on your specific symptom reactions.

  • 2
    Biological Veto Gate

    An 8-layer architecture that vetoes dangerous meals before you eat them, using L1 Sparsity Cutoffs and 90/10 Masking to isolate true triggers.

  • 3
    Pharmacokinetic (PK) Modeling

    We calculate your exact drug concentration based on your dosage schedule to protect you during high-risk "trough-to-peak" days.

  • 4
    Volumetric Dampener

    We understand that a sprinkle of garlic is safe, but a clove might trigger nausea. Our engine analyzes exact volume fractions.

✦ Sub-Population Performance

Pan-GLP-1 Molecule-Agnostic Validation (N=100)

Molecule Cohort Sensitivity NPV
Semaglutide
Wegovy • n=42
 42% 76.4% 92.1%
Tirzepatide
Mounjaro • n=38
38% 75.2% 90.8%
Liraglutide
Saxenda • n=12
12% 72.8% 89.4%
Dulaglutide
Trulicity • n=8
8% 71.5% 88.2%
✓ All cohorts exceed clinical target thresholds
Clinical Validation

Verified in Simulation Studio

We actively test our R16 architecture. In our latest on-device simulation runs (using real user logs):

  • ✓
    96% Bio-Specificity

    Successfully isolated true nausea triggers without falsely locking safe ingredients.

  • ✓
    Improved Dietary Yield

    Our algorithm increases dietary freedom, preserving safe meals that generic diet apps flag incorrectly.

Pharmacokinetic Safety Modeling

Actual 120-day patient simulation (Target: synth_003) overlaying drug concentration with symptom hazard timing.

PK Overlay Chart (synth_003)

Patient Retention (Kaplan-Meier)

100-Patient trial demonstrating significant reduction in dropout via dynamically-guided dietary intervention.

Kaplan-Meier Survival Chart
The Team

Built by Users.
Backed by Science.

We built Beezam because we needed it. As GLP-1 users ourselves, we lived the nightmare of nausea and food aversion. We are maintaining professional anonymity while in active development, but our pedigree speaks for itself:

CEO & Technical Founder

  • Technical Product Manager deploying AI in Enterprise environments
  • ML/AI Engineer
  • Data Scientist, Econometrician (Causal Inference)

COO & Strategy

  • Chicago Booth MBA
  • Transformation Manager
  • U.S. Army Veteran
B2B Enterprise & Pharma

Fixing the 30% Medication Drop-off Rate.

For Pharmaceutical Companies and Digital Health Clinics, GLP-1 medication adherence is the primary revenue bottleneck. Up to 30% of patients abandon treatment due to unmanaged GI side effects.

📈

Increase Patient LTV

Beezam acts as a predictive digital companion. By preventing severe nausea, we ensure patients tolerate titration steps, significantly increasing the Lifetime Value (LTV) of every prescription.

📊

Real-World Evidence (RWE)

Granular, meal-by-meal tolerability data across different GLP-1 molecules and dosages.

The Roadmap

Beyond Nausea: Protein Density Optimization

Rapid weight loss on GLP-1s often leads to dangerous muscle atrophy. Beezam's next evolution algorithmically optimizes recipes for high protein density without crossing volumetric risk thresholds, ensuring you lose fat, not muscle.

Ready to eat with confidence?

Join the users who are reclaiming their relationship with food on GLP-1s.

Get Beezam Now

Free to download. No subscription required for core features.